Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Financial benchmark analysis for 33 SEC-registered companies.
Sector Intelligence · Sprytne.com
The Medical Laboratories sector (SIC 8071) is led by LABCORP HOLDINGS INC. with $13.95B in annual revenue. Meanwhile, BillionToOne, Inc. leads in growth at +100.0% YoY. The most profitable player is QUEST DIAGNOSTICS INC with $992.0M net income.
Based on the latest SEC EDGAR 10-K annual filings · Verified public data
| Rank | Company | Revenue | Details |
|---|---|---|---|
| #1 | LABCORP HOLDINGS INC.LH | $13.95B | YoY: +7.2% |
| #2 | QUEST DIAGNOSTICS INCDGX | $11.04B | YoY: +11.8% |
| #3 | EXACT SCIENCES CORPEXAS | $3.25B | YoY: +17.7% |
| #4 | Fortrea Holdings Inc.FTRE | $2.72B | YoY: +1.0% |
| #5 | Natera, Inc.NTRA | $2.31B | YoY: +35.9% |
| #6 | RadNet, Inc.RDNT | $2.04B | YoY: +11.5% |
| #7 | Guardant Health, Inc.GH | $982.0M | YoY: +32.9% |
| #8 | Caris Life Sciences, Inc.CAI | $812.0M | YoY: +97.0% |
| #9 | VERACYTE, INC.VCYT | $517.1M | YoY: +16.0% |
| #10 | CareDx, Inc.CDNA | $379.8M | YoY: +13.8% |
| #11 | CASTLE BIOSCIENCES INCCSTL | $344.2M | YoY: +3.7% |
| #12 | Fulgent Genetics, Inc.FLGT | $322.7M | YoY: +13.8% |
| #13 | BillionToOne, Inc.BLLN | $305.1M | YoY: +100.0% |
| #14 | GRAIL, Inc.GRAL | $147.2M | YoY: +17.2% |
| #15 | BIODESIX INCBDSX | $88.5M | YoY: +24.1% |
| #16 | Personalis, Inc.PSNL | $69.6M | YoY: -17.7% |
| #17 | EXAGEN INC.XGN | $66.6M | YoY: +19.7% |
| #18 | AMERICAN SHARED HOSPITAL SERVICESAMS | $28.3M | YoY: +32.9% |
| #19 | PSYCHEMEDICS CORPPMDI | $19.7M | YoY: -10.9% |
| #20 | BioNexus Gene Lab CorpBGLC | $9.5M | YoY: -2.7% |
| #21 | CapForce Inc.OPGN | $4.3M | YoY: +2.2% |
| #22 | First Choice Healthcare Solutions, Inc.FCHS | $1.0M | YoY: -9.6% |
| #23 | Renalytix plcRNLXY | $100,000 | — |
| #24 | SERA PROGNOSTICS, INC.SERA | $81,000 | YoY: +5.2% |
| #25 | Aclarion, Inc.ACON | $75,730 | YoY: +65.6% |
| Rank | Company | YoY Growth | Details |
|---|---|---|---|
| #1 | BillionToOne, Inc.BLLN | +100.0% | Revenue: $305.1M |
| #2 | Caris Life Sciences, Inc.CAI | +97.0% | Revenue: $812.0M |
| #3 | Natera, Inc.NTRA | +35.9% | Revenue: $2.31B |
| #4 | AMERICAN SHARED HOSPITAL SERVICESAMS | +32.9% | Revenue: $28.3M |
| #5 | Guardant Health, Inc.GH | +32.9% | Revenue: $982.0M |
| #6 | BIODESIX INCBDSX | +24.1% | Revenue: $88.5M |
| #7 | EXAGEN INC.XGN | +19.7% | Revenue: $66.6M |
| #8 | EXACT SCIENCES CORPEXAS | +17.7% | Revenue: $3.25B |
| #9 | GRAIL, Inc.GRAL | +17.2% | Revenue: $147.2M |
| #10 | VERACYTE, INC.VCYT | +16.0% | Revenue: $517.1M |
| #11 | Fulgent Genetics, Inc.FLGT | +13.8% | Revenue: $322.7M |
| #12 | CareDx, Inc.CDNA | +13.8% | Revenue: $379.8M |
| #13 | QUEST DIAGNOSTICS INCDGX | +11.8% | Revenue: $11.04B |
| #14 | RadNet, Inc.RDNT | +11.5% | Revenue: $2.04B |
| #15 | LABCORP HOLDINGS INC.LH | +7.2% | Revenue: $13.95B |
| #16 | CASTLE BIOSCIENCES INCCSTL | +3.7% | Revenue: $344.2M |
| #17 | Fortrea Holdings Inc.FTRE | +1.0% | Revenue: $2.72B |
| Rank | Company | Net Income | Details |
|---|---|---|---|
| #1 | QUEST DIAGNOSTICS INCDGX | $992.0M | Margin: 9.0% |
| #2 | LABCORP HOLDINGS INC.LH | $876.5M | Margin: 6.3% |
| #3 | VERACYTE, INC.VCYT | $66.4M | Margin: 12.8% |
| #4 | CapForce Inc.OPGN | $12.0M | Margin: 278.5% |
| #5 | BillionToOne, Inc.BLLN | $7.5M | Margin: 2.4% |
| #6 | AMERICAN SHARED HOSPITAL SERVICESAMS | $2.2M | Margin: 7.7% |
| #7 | Perceptive Capital Solutions CorpPCSC | $837,468 | — |